Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Intervention1: Safoof Chobchini: 5 gm Orally Twice daily with water after meals
Control Intervention1: nil: nil
Sponsors
Central Council for Research in Unani Medicine CCRUM
Eligibility
Inclusion criteria
Inclusion criteria: (All of the following) 1. Patients of either sex in the age group of 18-65 years 2. Serum uric acid level: normal or above normal 3. Diagnosed cases of gout as per the ACR/ EULAR-2015 criteria for gout presenting with any of the following symptoms and signs: 4. Joint Pain [especially first metatarsophalangeal (MTP) joint] 5. Tenderness 6. Swelling 7. Redness
Exclusion criteria
Exclusion criteria: (Any of the following) 1. Clinical conditions involving joints e.g. Osteo-arthritis, Rheumatoid arthritis, Rheumatic arthritis 2. Pregnant and lactating women 3. Patients having any systemic diseases such as hypertension, diabetes mellitus, cardiovascular/cerebrovascular diseases, hepatic and renal disease, osteomalacia, osteoporosis 4. Patients with recent H/O dengue, chikungunya and viral fever 5. Grade-2 obesity (BMI >= 35) 6. Patients on long term medications 7. Patients taking drugs which increase serum uric acid levels (thiazide diuretics, etc.) and decrease serum calcium levels (furosemide, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in sign and symptoms of Niqris (Gout)Timepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine
Outcome results
None listed